The documentary 'NURSE: Empathy Heals' premiered on October 21 in Nashville, showcasing personal stories of nurses and the critical role of empathy in healthcare. It highlights the emotional challenges nurses face, especially during crises like the COVID-19 pandemic, and emphasizes the importance of supporting caregivers. Produced by Ballad Health and East Tennessee State University, the film aims to deepen public appreciation for nurses and their impact on communities. It is now available on Amazon Prime and other streaming platforms.
The documentary 'NURSE: Empathy Heals' shares nurses' stories, providing context for readers. For those following health-sector stocks, here is Pluang's market snapshot as of Oct 24, 2026 03:11 WIB: Of 150 priced US health stocks, 62 rose and 88 fell. Oscar Health Inc (OSCR) traded at USD 31.01 with a 1-day change of -6.93% and a typical hold time of 16 days. Inovio Pharmaceuticals Inc (INO) rose 5.76% to USD 0.84, with a 43-day hold time. Smith & Nephew plc (SNN) increased 5.54% to USD 30.85, held typically for 122 days.
Oxford Square Capital Corp. announced it will hold a conference call on October 30, 2026, at 9:00 AM Eastern time to discuss its third quarter 2026 earnings. Investors can join the call via a toll-free number, and a recorded replay will be available ...
Del Valle ISD Education Foundation in Austin, Texas, received the F1 Allwyn Global Community Award and a €100,000 grant from Allwyn during the 2026 Formula 1 United States Grand Prix. The funding supports the Fast Track initiative, which provides sch...
The Del Valle ISD Education Foundation in Austin, Texas, received the F1 Allwyn Global Community Award and a €100,000 grant from Allwyn to fund its 'Fast Track' initiative. This program aims to support 12,000 students by providing scholarships, teach...
The Del Valle ISD Education Foundation in Austin received the F1® Allwyn Global Community Award, securing a €100,000 grant from Allwyn to fund its Fast Track program. This initiative supports 12,000 students in disadvantaged areas by providing STEM s...
The CHMP of the European Medicines Agency has recommended approval for Johnson & Johnson's TALVEY (talquetamab) combined with daratumumab, with or without pomalidomide, for treating adults with relapsed or refractory multiple myeloma who have had at ...
